Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-11-13 17:45 |
Valneva et LimmaTech annoncent la vaccination du premier participant à l’essai …
|
French | 168.8 KB | ||
| 2024-11-13 17:45 |
Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge St…
|
English | 133.1 KB | ||
| 2024-11-12 07:00 |
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Hea…
|
English | 142.6 KB | ||
| 2024-11-12 07:00 |
Valneva fera des présentations et rencontrera les investisseurs lors de confére…
|
French | 143.7 KB | ||
| 2024-11-07 07:00 |
Valneva publie ses résultats financiers pour les neuf premiers mois de l’exerci…
|
French | 399.4 KB | ||
| 2024-11-07 07:00 |
Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates
|
English | 388.0 KB | ||
| 2024-11-06 08:30 |
VALNEVA - Déclaration d’actions et de droits de vote : 31 octobre 2024
|
French | 14.7 KB | ||
| 2024-11-06 08:30 |
VALNEVA - Declaration of shares and voting rights: October 31, 2024
|
English | 14.8 KB | ||
| 2024-10-21 17:45 |
Valneva effectuera des présentations sur le chikungunya lors de différentes con…
|
French | 119.0 KB | ||
| 2024-10-21 17:45 |
Valneva to Present on Chikungunya at Several Leading Scientific Conferences
|
English | 114.1 KB | ||
| 2024-10-16 17:45 |
Valneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigel…
|
English | 165.5 KB | ||
| 2024-10-16 17:45 |
Valneva and LimmaTech reçoivent le statut « Fast Track » de la FDA pour leur ca…
|
French | 195.1 KB | ||
| 2024-10-10 07:00 |
Valneva organise une journée investisseurs aujourd’hui à New York
|
French | 157.8 KB | ||
| 2024-10-10 07:00 |
Valneva Hosts Investor Day in New York City
|
English | 119.3 KB | ||
| 2024-10-04 07:30 |
Valneva SE - Déclaration d’actions et de droits de vote - 30 septembre 2024
|
French | 201.0 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
